Skip to content
healthcare.dev
Get a free key

Qulipta

NDC 0074-7094, Atogepant, tablet, from AbbVie Inc..

Product NDC
0074-7094
Status
Listed
Labeler
AbbVie Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215206
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7094 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOGEPANT60 mg/1

Pharmacologic classes

Calcitonin Gene-related Peptide Receptor Antagonist [EPC]; Calcitonin Gene-related Peptide Receptor Antagonists [MoA]

Package NDCNDC-11Package
0074-7094-04000747094044 TABLET in 1 BOTTLE (0074-7094-04)
0074-7094-300007470943030 TABLET in 1 BOTTLE (0074-7094-30)
0074-7094-70000747094704 TABLET in 1 BOTTLE (0074-7094-70)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8c8ab8f4-32bd-497a-befa-70c8a51d8d52

  • NADAC price for package 00074709430

    GET /v1/drugs/nadac/00074709430

Use it

Look up 0074-7094 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7094 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-7094. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.